Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Orgenesis Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 23 | 1 | 21 | −1 |
| Shares | 2.92M | 54.2K | 2.22M | −649.8K (−22.6%) |
| Value | $4.15M | $77.0K | $4.33M | +$257.6K (+6.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Orgenesis Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Chapin Davis, Inc. | 20,000 | $39.0K | 0.02% |
| Citadel Advisors LLC | 15,319 | $29.9K | 0.00% |
Sold out (3)
Institutions that held Orgenesis Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 29,269 | $42.0K |
| Royal Bank of Canada | 165 | $0 |
| Simplex Trading, LLC | 334 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Orgenesis Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ronit Capital LLP | 54,167 | $77.0K |